Results 201 to 210 of about 86,629 (276)

National multiple myeloma cohort: Gaps and opportunities for research in Brazil. [PDF]

Hematol Transfus Cell Ther
Moreira do Amaral D.
europepmc   +1 more source

α-Aminoboronic Acid Moieties in Boro Dipeptides Modulate Proteasome Subunit Selectivity and Provide Access to Compounds with Potent Anticancer and Anti-Inflammatory Activity. [PDF]

J Med Chem
Strašek Benedik N, Šterman A, Smrdel L, Pajk S, Gobec S, Časar Z, Gobec M, Sosič I.   +7 more
europepmc   +1 more source

Dermatological Manifestations of Amyloid Light-Chain (AL) Amyloidosis: A Case Report Highlighting Early Diagnosis and Treatment. [PDF]

Cureus
Gill SS, Kamboj T.
europepmc   +1 more source

The Evolving Experience and Outcomes of Pediatric Kidney Transplant in Abu Dhabi, UAE (2010-2024). [PDF]

Int J Nephrol
Beyyumi E, Al Dhaheri W, Ahmad N, Zaman MB, Khasawneh EA.   +4 more
europepmc   +1 more source

Bortezomib-encapsulated metal–phenolic nanoparticles for intracellular drug delivery

Haidong Zhou, Hongyu Xu, Jiaping Man, Gang-xiang Wang   +3 more
openalex   +2 more sources

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: A New York Cancer Consortium trial [PDF]

, 2016
et al,, Ma, Cynthia X, Naughton, Michael
core   +2 more sources

Frequency-adjusted daratumumab-based regimen versus bortezomib/dexamethasone in newly diagnosed AL amyloidosis: a matched-cohort study. [PDF]

Ann Med
Zheng W, Zhou M, Xing Y, Zhao J, Liu B, Li W, Sun S.   +6 more
europepmc   +1 more source

Successful Treatment of Refractory IgA-Mediated Autoimmune Hemolytic Anemia With Bortezomib. [PDF]

EJHaem
Neri S, Eckhardt CL, Beuger BM, Folman F, Rettenbacher E, Matlung HL, Kuijpers TW, Vos JMI, van Bruggen R.   +8 more
europepmc   +1 more source

Novel therapeutic agents and intensive chemotherapy improve survival outcomes in patients with mantle cell lymphoma. [PDF]

Am J Cancer Res
Lin ZC, Wang MC, Lin TL, Kuo MC, Kao HW, Chang H, Hung YS, Ma MC, Ong YC, Ou CW, Kuo CY, Chen YY, Huang YM, Shih HJ.   +13 more
europepmc   +1 more source

Therapeutic Potential of Exportin 1 and Aurora Kinase A Inhibition in Multiple Myeloma Cells. [PDF]

Hematol Rep
Okabe S, Tanaka Y, Otsuki S, Moriyama M, Yoshizawa S, Gotoh A, Akahane D.   +6 more
europepmc   +1 more source